Related Experiment Video
Updated: Apr 22, 2026
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways
1Department of Neurosurgery, The First People's Hospital of Yancheng Affiliated with Nantong University, Yancheng 224001, PR China.
Abstract:
As a common malignant tumor, glioma has long been a refractory disease in the field of neurosurgery. Exploration of its etiology, pathogenesis, biological characteristics, and new treatment measures is a hot topic as well as a problem most difficult to solve in the neurosurgical division. In recent years, the role of Nodal and its feedback inhibitor Lefty in tumors has drawn more and more attention and may form a new target for cancer therapy. Western blot detection indicated that there was almost no expression of Lefty protein in glioma cells. Transfection of Lefty-overexpressing vector into GBM8401 and GBM glioma cells significantly decreased the expression of Nodal. Nodal can significantly increase the phosphorylation levels of Smad2 and Smad3 and activate the ERK1/2 pathway; meanwhile, Nodal promotes the proliferation and invasion of glioma cells and inhibits their apoptosis. However, when cells were co-transfected with both Lefty- and Nodal-overexpressing vectors, Lefty inhibited the above effects of Nodal in glioma cells, hence significantly reduced the levels of phosphorylated Smad2, Smad3, and ERK1/2, inhibited the proliferation and invasion of glioma cells, and increased their apoptosis. These results indicate that in glioma cells, Lefty inhibits Nodal-mediated activation of Smad and ERK1/2 signaling pathways, thereby suppressing the promoting effect of Nodal on tumor growth.
Insights
Lefty protein suppresses glioma growth by inhibiting the Nodal signaling pathway. This study reveals Lefty as a potential therapeutic target for treating glioma, a challenging neurosurgical condition.
Area of Science:
- Oncology
- Molecular Biology
- Neurosurgery
Background:
- Glioma is a common and difficult-to-treat malignant tumor.
- Nodal and its inhibitor Lefty are emerging as potential cancer therapy targets.
- Lefty protein expression is notably absent in glioma cells.
Purpose of the Study:
- To investigate the role of Lefty in regulating Nodal signaling in glioma cells.
- To determine if Lefty can inhibit glioma cell proliferation and invasion.
- To explore Lefty as a potential therapeutic target for glioma.
Main Methods:
- Western blot analysis to detect Lefty protein expression.
- Transfection of glioma cells with Lefty- and Nodal-overexpressing vectors.
- Assessing the effects on Smad2/3 and ERK1/2 phosphorylation, cell proliferation, invasion, and apoptosis.
Main Results:
- Lefty overexpression significantly reduced Nodal expression in glioma cells.
- Nodal promoted glioma cell proliferation and invasion by activating Smad and ERK1/2 pathways.
- Lefty counteracted Nodal's effects, inhibiting proliferation and invasion while promoting apoptosis.
Conclusions:
- Lefty inhibits Nodal-mediated Smad and ERK1/2 signaling in glioma cells.
- Lefty suppresses glioma growth by inhibiting Nodal's pro-tumorigenic effects.
- Lefty represents a promising therapeutic target for glioma treatment.
